Synergy Pharmaceuticals Company

Synergy Pharmaceuticals is a biopharmaceutical company developing novel therapies for the treatment of gastrointestinal conditions.

Last Funding Type: Post-IPO Debt
Funding Status: IPO
Headquarters: New York, New York, United States
Founded Date: 1992-02-11
Last Funding Date: 2017-09-05
Total Funding: 407231243.0
Technology: Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Employee Number: 101-250
Estimated Revenue: $10M to $50M
Investors Number: 1.0
Industry: Early Drug Development